Tackling sepsis with point-of-care testing of PCT

Klinikum Ernst von Bergmann uses point-of-care testing of PCT as an aid in the diagnosis of sepsis

The Klinikum Ernst von Bergmann relies on Radiometer’s AQT90 FLEX analyzer for early and convenient measurement of procalcitonin (PCT), the biomarker of choice to aid in the diagnosis of sepsis.

The Klinikum Ernst von Bergmann hospital—one of the largest hospitals in the Berlin/Brandenburg region in Germany—is an academic teaching hospital with over 1,000 beds. It offers a range of services, such as primary prevention and inpatient and outpatient treatments. It is also a referral hospital for smaller hospitals in the area.

The Emergency Department (ED) department is busy, seeing over 45,000 patients a year. The department has an AQT90 FLEX analyzer, which includes the biomarker procalcitonin (PCT).

Dr. Michael Oppert, Head of the Intensive Care and Emergency Medicine departments, explains that sepsis is increasingly a focal point in emergency medicine. He states, “In Germany, the average age of people attending ED is increasing, and the morbidity of the patients is much more severe now than a couple of years ago. Both surgical and medical treatments are also more invasive and this makes patients more susceptible to complications and severe infections.”

About the hospital

  • Klinikum Ernst von Bergmann gemeinnützige GmbH, Germany

  • Intensive Care and Emergency Medicine departments

  • 1,000-bed academic teaching hospital

  • Referral hospital for the Berlin/Brandenburg region

  • ED department with 15-bed admissions unit, equipped with AQT90 FLEX analyzer and ABL blood gas analyzers

  • 45,000 patients a year presenting at ED

  • 24-bed intensive care unit, including intermediate care, equipped with an ABL blood gas analyzer

Making a diagnosis of sepsis

Sepsis is a common and severe infection related condition that can be difficult to identify. Patients who have sepsis may present symptoms of high fever, hypothermia, delirium or an altered level of consciousness.

Other symptoms include organ dysfunction, reduced urine output, shortness of breath and low blood pressure. If the patient also has an elevated level of lactate and mild acidosis, the probability of sepsis is high. This patient should be monitored and treated accordingly. The myriad of symptoms makes diagnosing sepsis challenging.

Dr. Oppert explains, “When a patient is clearly septic, treatment can begin without any further investigations.

However, some patients fall into a grey area, where there is a clinical suspicion of sepsis but the diagnosis is not clear cut. In this situation, we administer antibiotics while further tests are performed: point-of-care testing (POCT) for infection markers, such as PCT and C-reactive protein (CRP), and lactate, as well as blood cultures. Both infection and inflammation—for example, due to autoimmune diseases, infection, and severe trauma—cause an increase in CRP. In contrast, PCT remains low in patients with inflammatory states, but is elevated when a bacterial infection is present.”

He continues, “For these patients, the measurement of PCT using the AQT90 FLEX analyzer is a great advantage, helping to differentiate patients with sepsis from those with non-infectious causes of systemic inflammations.”

The crucial thing is that we don´t waste time.

- Dr. Oppert, Head of the Intensive Care and Emergency Medicine departments

Dr. Michael Oppert, Head of the Intensive Care and Emergency Medicine departments

Dr. Michael Oppert, Head of the Intensive Care and Emergency Medicine departments

Every minute counts

It is essential to make a diagnosis quickly for the best possible outcome for the septic patient. 

While central laboratories may have an acceptable turnaround time from receiving the sample to producing a result, the overall ‘vein to brain’ time—the time between drawing the blood from the patient’s vein to the result reaching the doctor’s brain—will be longer. More time needs to be allocated for other tasks, such as transporting and preparing samples for testing, and validating and uploading results to the electronic patient record. 

Rapid turnaround times are vital and, compared to central laboratory testing, POCT can deliver results in minutes, rather than hours.

Dr. Oppert states that “We know that time is life for a septic patient. Every hour’s delay in initiating the correct treatment—fluids, antibiotics, microbiology testing, etc. —increases the mortality risk by as much as eight percent.”

When a result is needed urgently, particularly out of hours, the AQT90 FLEX analyzer is invaluable, delivering the results we need rapidly at the point of patient care.

- Dr. Oppert, Head of the Intensive Care and Emergency Medicine departments

No sample preparation necessary 

In a fast-paced emergency environment, POCT must not only be quick but also simple to perform and require minimal hands-on time. 

This is where the AQT90 FLEX analyzer comes in. It is readily accepted by nursing staff because it is easy to use and sample preparation is unnecessary. 

Dr. Oppert further explains, “With the AQT90 FLEX analyzer, PCT testing is quick and easy. There is no need to centrifuge the tube and pipette plasma into another container. This is so important in a busy emergency department. You simply draw a blood sample, place the tube in the analyzer and press go. Accurate, reliable results can be available—and the printout in the doctor’s hand—in less than 21 minutes.” 

Cookies将被该网站使用

Use of cookies
请输入您已注册的E-mail

请输入有效的电子邮箱地址

继续
点击“继续”即表示您认可 用户数据政策通知
雷度米特使用Microsoft Azure AD验证客户访问权限。如果您已是雷度的注册用户,系统将跳转至Azure,并使用您的Azure凭证登录。
您已经注册
雷度米特使用Microsoft Azure AD验证客户访问权限。如果您已注册,则将转到Azure AD使用您的Azure AD凭证登录。
谢谢

我们将尽快向您发送邀请邮件,以便使用Microsoft Azure AD登录

雷度米特使用Microsoft Azure AD验证客户访问权限。
抱歉

您的电子邮箱并未注册我们的服务

雷度米特使用Microsoft Azure AD验证客户访问权限。
我们之前已经通过邮件发出了邀请

请点击邮件中的“开始注册”完成注册流程

雷度米特使用Microsoft Azure AD验证客户访问权限。
抱歉

由于系统错误,我们无法处理您的请求

抱歉

该账户未获得访问门户的权限

雷度米特使用AZURE AD为客户和合作伙伴提供客户网站上文档、资源和其他服务的安全访问。

如果您的组织已在使用AZURE AD,您可使用相同的凭证访问雷度米特的客户网站。

主要优点

  • 允许使用现有的Active Directory凭证
  • 单点登录体验
  • 使用相同的凭证访问服务

请求获得批准后,您将收到访问我们服务的邀请邮件。

如果您接受邀请,并且您的组织已在使用AZURE AD,您可使用相同的凭证访问雷度米特的客户网站。否则,系统将通过邮件发送给您一个一次性密码进行登录。